Companies / Switzerland

Teva, Novartis Linked To Aurobindo

February 2007 | Company Finance Alert

Israeli generics firm

To read the full article, please choose one of the following options:

Subcribers please log in

Related Insight Articles

Nanogen Launches Advanced Hepatitis C Medicine

Industry / Switzerland BMI Core View: Drugmakers based in emerging markets will increasingly produce hard-to-manufacture pharmaceuticals. Firms in developing countries enjoy low operating costs, but have traditionally lacked...

January 2011

Sprycel And Tasigna See Upside From Gleevec Test

Industry / Switzerland BMI Core View: The development and marketing of therapeutics in combination with diagnostics will become more common. It is increasingly clear that the 'one size fits all' approach to developing pharmaceuticals...

August 2010

Novartis Invests In Rural Healthcare Scheme

Industry / Switzerland BMI Core View: Sales forces will contract in developed states and expand in emerging markets. The primary cause of this trend is the declining influence of US and Western European doctors on prescribing...

July 2010

Roche Maintains Consistent Pricing Policy

Industry / Switzerland BMI Core View: Drugmakers will increasingly use differential pricing in emerging markets. Pharmaceutical companies generally price their patented medicines at the maximum the market will bear in light...

May 2010

Novartis Expands In The Leading Emerging Pharmaceutical Market

Industry / Switzerland Basel-based multinational Novartis is to expand its sales team and build its research capabilities in China, according to CEO Joe Jimenez. The former tactic will boost sales immediately, while the latter...

April 2010